1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-25-450
PAR-25-450National Institutes of HealthR21

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

Deadline
2027-02-17
167 days left
Award ceiling
—
Awards
—
Posted
2025-09-22

Summary

This Notice of Funding Opportunity (NOFO) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. […]

The rest of this announcement — free with an account

  • →The full announcement text, not the first two sentences
  • →All 3 review criteria reviewers score this against, extracted from this announcement
  • →Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
  • →What similar funded projects received, from 219,000 past awards
Create free accountSign in

No card required. Browsing and your first match are free.

rare-disease

More from National Institutes of Health

See all →
RFA-RM-27-003 • National Institutes of Health

NIH Director’s Transformative Research Award for Individual and Group Science (R01 Clinical Trial Optional)

The NIH Director's Transformative Research Award supports collaborative investigative teams or individual scientists who propose unusually bold and innovative research projects, which, if successful, would have a major impact in a broad area of relevance to the NIH.

3 review criteria on file
amount not statedDue 2026-09-030 days left
PA-27-102 • National Institutes of Health

NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)

S. technology development and commercialization.

6 review criteria on file
amount not statedDue 2026-09-052 days left
PA-27-101 • National Institutes of Health

NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

S. technology development and commercialization.

7 review criteria on file
amount not statedDue 2026-09-052 days left
PA-27-100 • National Institutes of Health

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

S. technology development and commercialization.

6 review criteria on file
amount not statedDue 2026-09-052 days left

Also in rare-disease

PAR-26-040 • National Institutes of Health

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

The National Library of Medicine (NLM) wishes to advance groundbreaking and innovative research in bioinformatics, translational bioinformatics and computational biology, which are related areas of biomedical informatics that aim to understand biological data using storage, analytic and interpretive methods.

3 review criteria on file
$250,000award ceilingDue 2026-10-05
PAR-25-185 • National Institutes of Health

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Rapid advances in genotyping and next generation sequencing technologies have led to the identification of genetic variants that are associated with a wide variety of congenital defects including structural congenital anomalies (SCAs), intellectual developmental disabilities (IDDs) and inborn errors of metabolism (IEMs).

3 review criteria on file
amount not statedDue 2026-10-05
PAR-27-057 • National Institutes of Health

Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed)

6 years.25 billion fewer life years for the United States population.

3 review criteria on file
$500,000award ceilingDue 2026-10-05

Official announcement: https://grants.nih.gov/grants/guide/pa-files/PAR-25-450.htmlSource: nih_guide+grants_gov. Always confirm dates with the funder.